• SA39 Targeted Treatments for Patients with Relapsed and/or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): A Systematic Literature Review (SLR) of Randomized Clinical Trials (RCTs)

    Dec 1, 2023, 00:00

  • PT10 Opioid Tapering and Its Associations with Risk of Opioid Use Disorder and Mortality Among Older Adults

    Dec 1, 2023, 00:00

  • HTA280 Pharmacoeconomic Research As an Area for Drugs Comparison

    Dec 1, 2023, 00:00

  • MSR131 Prospects for Automation of Systemic Literature Reviews (SLRs) With Artificial Intelligence and Natural Language Processing

    Dec 1, 2023, 00:00

  • EPH86 Access to a First Disease-Modifying Therapy Leads to a Disproportionate Increase in the Patient Population Diagnosed with a Rare Disease

    Dec 1, 2023, 00:00

  • EE372 Modeling the Cost-Effectiveness in a Sub-Population: Tepotinib Versus Chemoimmunotherapy (C+IO) in Untreated Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring MET Exon 14 (METEX14) Skipping

    Dec 1, 2023, 00:00

  • EE199 A Systematic Literature Review of Economic Evaluations of Community-Based Interventions to Improve Mobility, Continence, and Psychological Wellbeing in Individuals with Neuro-Physical Disabilities

    Dec 1, 2023, 00:00

  • MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey

    Dec 1, 2023, 00:00

  • SA45 Natural Evolution of Chronic Kidney Disease in Diabetic Patients: Costs and Consequences in Portuguese Reality

    Dec 1, 2023, 00:00

  • CO166 Efficacy of Lecanemab in Patients With Early Alzheimer Disease: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • CO66 Improvements in the Peabody Developmental Motor Scale, Second Edition (PDMS-2) and Correlation With Bayley-III Scores and Motor Milestones in Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd)

    Dec 1, 2023, 00:00

  • HTA189 A Critical Appraisal of Economic Evaluations in RSV

    Dec 1, 2023, 00:00

  • EE556 Beclometasone/Formoterol/Glycopyrronium Vs. Fixed and Open Combinations of Inhaled Corticosteroids, Long-Acting B2-Agonist, and Long-Acting Muscarinic Antagonist in Adults with Uncontrolled Asthma: A Network Meta-Analysis

    Dec 1, 2023, 00:00

  • EE570 A Swedish Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease

    Dec 1, 2023, 00:00

  • Medical Technologies

    Dec 1, 2023, 00:00

  • EPH140 Prevalence Estimation of Thymidine Kinase 2 Deficiency: An Ultra-Rare Autosomal Recessive Mitochondrial Disease

    Dec 1, 2023, 00:00

  • PT36 Real-World Analysis on Therapeutic Pattern and Economic Burden of Androgen-Receptor Signaling Inhibitors (ARSI) and Taxane-Based Chemotherapy Treated Metastatic Castration-Resistant Prostate Cancer Patients in Italy

    Dec 1, 2023, 00:00

  • MSR142 Multi-State Modelling Incorporating a Combined Additive and Relative Hazards Model

    Dec 1, 2023, 00:00

  • EE674 Healthcare Resource Use and Costs Associated with Endometrial Cancer Treatment in the Private Setting in Brazil

    Dec 1, 2023, 00:00

  • OP23 Best Practice for Publication of Health Economics and Outcomes Research/Real-World Evidence (RWE) - a Pilot Study on Guidance Needs and Scope for Development

    Dec 1, 2023, 00:00

  • EE119 Development of a De Novo Model to Assess the Cost-Effectiveness of a New Treatment Option for Patients With Primary Immunoglobulin a Nephropathy (IgAN)

    Dec 1, 2023, 00:00

  • MSR77 Can Bayesian Informative Priors Improve Extrapolation of Immature Overall Survival? A Case Study in Advanced Melanoma

    Dec 1, 2023, 00:00

  • HTA306 The Combination Conundrum: Comparing Reimbursement Outcomes for Oncology Combination Products in the UK and France

    Dec 1, 2023, 00:00

  • HTA221 Improving the Reimbursement Application Process: A Predictive Model for Identifying Key Subgroup Specification Parameters for Anti-Obesity Medication

    Dec 1, 2023, 00:00

  • The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non–Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • HTA191 Discussion of Health Inequalities in the NICE Single Technology Appraisal Process: A Review of Recent Submissions in NHS England Core20PLUS5 Focus Clinical Areas

    Dec 1, 2023, 00:00

  • PCR56 Is Walking As Important As Muscle Strength After Stroke? Preference Weighting of ICF's Core Elements

    Dec 1, 2023, 00:00

  • Using Discrete Choice Experiments to Elicit Carers' and Patients' Preferences

    Dec 1, 2023, 00:00

  • HSD11 Hospital Capacity Tool to Assess the Potential Impact of Using a Fixed Dose Combination of Pertuzumab/Trastuzumab for Subcutaneous Injection Versus Intravenous Pertuzumab/Trastuzumab in HER2+ Breast Cancer

    Dec 1, 2023, 00:00

  • EE409 The Costs of Unaddressed Hearing Loss as a Basis for Cost-Effectiveness Analyses

    Dec 1, 2023, 00:00

  • HPR145 Access of Rare Disease Treatments in the Nordics

    Dec 1, 2023, 00:00

  • PT30 Will Health Technology Assessment (HTA) Bodies in Europe Accept Evidence from an External Control Arm to Supplement Evidence from Clinical Trials for Chronic Diseases?

    Dec 1, 2023, 00:00

  • HTA238 Oncological Combination Therapies in the Context of the Early Benefit Assessment According to AMNOG: Status Quo and Quo Vadis

    Dec 1, 2023, 00:00

  • RWD155 Using Real-World-Evidence to Inform Pathway Evaluations at NICE: Benefits and Challenges

    Dec 1, 2023, 00:00

  • HSD79 Assessment of Patient Satisfaction with Public Pharmacies Dispensing High-Cost Drugs in Greece

    Dec 1, 2023, 00:00

  • EE403 Economic Analysis of Dupilumab Use in Patients With Chronic Rhinosinusitis With Nasal Polyps in Colombia

    Dec 1, 2023, 00:00

  • PCR51 Patient-Centered Instrument Design: Problems and Solutions Based on Patient Feedback

    Dec 1, 2023, 00:00

  • MT11 Potential Budget Impact of Negative Pressure Wound Therapy with Instillation and Dwell Time Versus Control Therapies for Wound Management in Mexico

    Dec 1, 2023, 00:00

  • EE504 Buprenorphine–Naloxone Film Yields Cost Savings in Administration Time Compared With Sublingual Tablets in Sweden

    Dec 1, 2023, 00:00

  • EE266 A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients With Iron Deficiency Anemia in China

    Dec 1, 2023, 00:00

  • HSD59 Exploring Factors for Regional Differences in Inappropriate Psychotropic Drug Prescribing: Ecological Study Using a Claims Database in Japan

    Dec 1, 2023, 00:00

  • EE205 The Impact of the COVID-19 Pandemic on Physician Visits Among Patients Diagnosed with Breast Cancer and Heart Failure in the United States

    Dec 1, 2023, 00:00

  • MT39 Development of an Early Economic Model to Assess the Cost-Effectiveness of a Novel Technology for the Treatment and/or Prevention of Cataracts

    Dec 1, 2023, 00:00

  • PCR38 A Systematic Literature Review of the Humanistic Burden Associated with Geographic Atrophy

    Dec 1, 2023, 00:00

  • MSR117 Identifying Economic Insecurity Among Psoriasis Patients Using Natural Language Processing and Unstructured Clinical Notes

    Dec 1, 2023, 00:00

  • EE458 Benefits, Costs and Cost Effectiveness of a Chronic Heart Failure Disease Management Program for Austria – a Decision-Analytic Modeling Study

    Dec 1, 2023, 00:00

  • HPR166 Access to Innovative Treatment Through Performance-Based Contracts in Fran Recommendations From Multidisciplinary Experts’ Workshops

    Dec 1, 2023, 00:00

  • HTA27 Use of Clinical Outcome Assessments in Health Technology Appraisals for Rare Disease Indications: A Review of UK, US, and Canadian Submissions

    Dec 1, 2023, 00:00

  • HPR95 Public-Private Partnership Model in Oncology: Business Opportunities for Next Generation Contract Research Organizations in the Context of CancerX

    Dec 1, 2023, 00:00

  • PT29 Predicting PICOs for EU Joint Clinical Assessment: Lessons from PICOs in Relative Effectiveness Assessments (REA) from EUnetHTA Joint Action 3 Project

    Dec 1, 2023, 00:00

  • HTA143 Drug Market Access Delays in Fran What Role May Cost-Effectiveness Evaluations Play in Varying These Timescales?

    Dec 1, 2023, 00:00

  • CO76 Does Next Generation Sequencing (NGS) Improve Outcome in Non-Small Cell Lung Cancer (NSCLC)? A Real-World Data (RWD) Example

    Dec 1, 2023, 00:00

  • EE61 Relationship between Health-Related Quality of Life and Productivity Loss and Indirect Costs of Leukemia and Lymphoma Patients and Caregivers: Estimates from a Cross-Sectional Study from Portugal

    Dec 1, 2023, 00:00

  • EE586 Comparison of Enteral Nutritional Therapy to Induce and Maintain Remission in Paediatric Patients with Mild-to-Moderate Crohn’S Disease: A Cost-Effectiveness Analysis in the UK

    Dec 1, 2023, 00:00

  • EE610 Opportunities to Improve the Cost Effectiveness of the Care Pathway in Acute Ischemic Stroke: A Decision Tree Analysis

    Dec 1, 2023, 00:00

  • CO143 Identifying Evidence Gaps for Hemophilia B by Developing a Factsheet Using Targeted Review of Literature: Shaping the Future Real-World Evidence Studies

    Dec 1, 2023, 00:00

  • EE232 Cost-Effectiveness of a Genomic Profiling Test for HRD Determination in Ovarian Cancer Into the Current Clinical Practice for Platinum-Sensitive Patients With Advanced Ovarian Cancer in Greece

    Dec 1, 2023, 00:00

  • HTA349 Impact of Technical Exchanges on CEESP Reservations: Analysis of the 2022 CEESP Opinions

    Dec 1, 2023, 00:00

  • EE334 Five-Year Budget Impact of Community-Based HIV Testing Strategies for Oral Pre-Exposure Prophylaxis Scale-up in Western Kenya: A Modeling Analysis

    Dec 1, 2023, 00:00

  • EPH150 Impact CKD: The Growing Burden of CKD in Spain

    Dec 1, 2023, 00:00

  • HPR205 Predicting Drug Price Erosion in Germany Associated With Indication Expansion, to Understand the Potential Launch Price Benchmark for a New Product

    Dec 1, 2023, 00:00

  • P8 The Dutch Lock Procedure for Reimbursement Works as Intended

    Dec 1, 2023, 00:00

  • HPR81 Challenges in the Identification of Unmet Needs in Rare Diseases: Towards the Development of a Framework

    Dec 1, 2023, 00:00

  • HTA58 Scoping Mock-Up: What Can We Learn From an EU-4 Experiment for EU HTA?

    Dec 1, 2023, 00:00

  • HPR77 Community-Based Health Insurance and Migrant Organizations: Senegalese Associations’ Response to Legal Vulnerability and Transnational Medical Needs

    Dec 1, 2023, 00:00

  • PT11 Overall Survival of Patients with Lung Cancer Newly Diagnosed in the Period of the COVID-19 Pandemic Compared to Patients with an Incident Diagnosis Before the Pandemic: A Retrospective Analysis of German Claims Data

    Dec 1, 2023, 00:00

  • PCR2 Patients’ and Healthcare Professionals’ Preferences Regarding Lipid-Lowering Therapies for Patients with Very High Cardiovascular Risk and Established Atherosclerotic Cardiovascular Disease

    Dec 1, 2023, 00:00

  • RWD49 Real-World Evidence From a Federated Data Network to Reduce Uncertainty in the Long-Term Extrapolations of Oncology Treatments

    Dec 1, 2023, 00:00

  • HPR177 Overview of Reimbursement Criteria for Bariatric Surgery in 23 Countries

    Dec 1, 2023, 00:00

  • HTA204 A Retrospective of the HAS Economic Appraisals Over the Last Ten Years

    Dec 1, 2023, 00:00

  • PCR136 The Burden of Systemic Mastocytosis in Select European Countries: Evidence from the Prism Patient Survey

    Dec 1, 2023, 00:00

  • MSR122 Relationship Between 3-Meter Backward Walk Test and Grip Strength Test in Community-Dwelling Young-Older Adults

    Dec 1, 2023, 00:00

  • EE386 Budget Impact of Durvalumab for the Treatment of Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Brazilian Private Healthcare System

    Dec 1, 2023, 00:00

  • EPH131 Landscape Analysis of Alzheimer's Disease-Specific Caregiver Outcome Assessments

    Dec 1, 2023, 00:00

  • HTA276 Comparison of Health Technology Assessment Systems: A Review of Their Impact on Expenditure and Outcomes

    Dec 1, 2023, 00:00

  • HTA112 The NICE Medical Technologies Evaluation Program: An Analysis of Clinical and Economic Evidence Evaluated in Published Medical Technology Guidance

    Dec 1, 2023, 00:00

  • MSR163 Artificial Intelligence (AI)-Based Screening: Exploration of Differences in Two Health Technology Assessment (HTA)-Compliant Systematic Literature Reviews (SLRS)

    Dec 1, 2023, 00:00

  • EE713 Cost-of-Illness of Generalized Pustular Psoriasis in Italy

    Dec 1, 2023, 00:00

  • HPR64 Lack of Incentives, Lack of Sanctions, Lack of Complian Early Notification of Impending Drug Shortages in Eight European Countries

    Dec 1, 2023, 00:00

  • HTA138 Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on French Medico-Economic Evaluation – a Quantitatve Analysis

    Dec 1, 2023, 00:00

  • HPR186 Implementation of Risk-Sharing Agreement in Patients with Lung Cancer Treated with Immunotherapy Based on RWD in the Czech Republic

    Dec 1, 2023, 00:00

  • MSR30 Existing Practices for the Identification, Selection, or Assessment of Registries and Real-Word Data for Regulatory/HTA Purposes: A More-EUROPA Project Systematic Review

    Dec 1, 2023, 00:00

  • EE108 Cost-Effectiveness Analysis of Abrocitinib Versus Dupilumab for Treatment of Moderate-to-Severe Atopic Dermatitis in Chinese Adults

    Dec 1, 2023, 00:00

  • PT28 Lost in PICO? a Simulation of the EU HTA Scoping Process

    Dec 1, 2023, 00:00

  • HTA317 Comparing Ultra-Rare Disease Pathways Within the United Kingdom: Can Different Processes Lead to Market Access Variations?

    Dec 1, 2023, 00:00

  • CO36 Comparative Analysis of Coding Schemas for Assessing Major Bleeding Risk Between Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin

    Dec 1, 2023, 00:00

  • HSD8 Enhancing Prostate Cancer Care by Optimizing Patient Engagement with Digital Tools

    Dec 1, 2023, 00:00

  • EPH40 Evolving Impact of the COVID-19 Pandemic in Chronic Dialysis Recipients According to Wave Sub-Periods

    Dec 1, 2023, 00:00

  • HPR32 Is NRDL Supporting Access or Hindering Access in China? A Time-Trend Analysis From 2017-2022

    Dec 1, 2023, 00:00

  • MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)

    Dec 1, 2023, 00:00

  • HTA161 Can We Elicit a Willingness to Pay Threshold for Oncology Treatments in Denmark?

    Dec 1, 2023, 00:00

  • HSD34 Real-World Usage of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with Axial Spondyloarthritis in Germany

    Dec 1, 2023, 00:00

  • HTA215 Utilization of RWE in HTA Appraisals in England, Scotland, Germany, and France

    Dec 1, 2023, 00:00

  • P14 Understanding Patients' Preferences for Remote Monitoring in Parkinson's Disease: Insights from a Mixed-Methods Study

    Dec 1, 2023, 00:00

  • EE330 Economic Burden of Biologic Therapy for Chinese Patients with Crohn's Disease

    Dec 1, 2023, 00:00

  • HPR11 Oncolytic Therapies in China: Laying the Groundwork for a Successful Launch

    Dec 1, 2023, 00:00

  • PT44 Cost-Effectiveness of Olaparib Vs. Rucaparib for Patients with Metastatic Castration-Resistant Prostate Cancer – the Canadian Perspective

    Dec 1, 2023, 00:00

  • HTA222 Antimicrobial Resistan Evolving Changes in Health Technology Assessment and Reimbursement of New Treatment Options

    Dec 1, 2023, 00:00

  • RWD128 The Burden of Illness in Duchenne Muscular Dystrophy: Evidence Gaps and Research Needs

    Dec 1, 2023, 00:00

  • OP24 Collaborating for Better Outcomes: How Can Value-Based Partnerships Unlock Value Across Stakeholder Groups and Elevate Pharma's Role Within Healthcare Ecosystems?

    Dec 1, 2023, 00:00

  • PCR47 Consumer Preferences for Attributes of Influenza Vaccines in the United States: Results from a Discrete-Choice Experiment Study

    Dec 1, 2023, 00:00

  • EE324 Clinical and Economic Evaluation of the Potential Implementation of P4P for Type 2 Diabetes in Bulgaria

    Dec 1, 2023, 00:00

  • PCR77 Symptom Burden and Health-Related Quality of Life (HRQoL) in Gastrointestinal (GI) Cancers: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • CO11 Medication Adherence in Osteoporosis Treatments and the Impact in Patients' Quality of Life

    Dec 1, 2023, 00:00

  • P11 Real-World Evidence of Total Colonoscopy for Colorectal Cancer Screening Based on Test Performance RCTs

    Dec 1, 2023, 00:00

  • PCR48 Health-Related Quality of Life in Children with Pneumococcal Disease: What Can We Learn from Cost-Effectiveness Analyses of Pneumococcal Vaccines?

    Dec 1, 2023, 00:00

  • HSD74 Cost Savings as a Result of Biosimilar Medications Adoption in One of the Tertiary Governmental Hospitals in Riyadh, Saudi Arabia.

    Dec 1, 2023, 00:00

  • EE381 Health Benefits and Cost-Effectiveness Analysis of Early Breast Cancer Diagnosis in Bulgaria

    Dec 1, 2023, 00:00

  • PCR184 A Systematic Literature Review of Patient-Reported Outcomes With Nivolumab Across Lung Cancers

    Dec 1, 2023, 00:00

  • PT37 A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders

    Dec 1, 2023, 00:00

  • EPH83 Ecological Study of the Incidence and Prevalence of Cancer Associated with Social Determinants of Health

    Dec 1, 2023, 00:00

  • P24 Improving Efficiency of Living Systematic Literature Reviews (SLR) with Artificial Intelligence (AI): Assisted Extraction of Population, Intervention/Comparator, Outcome, and Study Design (P-I/C-O-S)

    Dec 1, 2023, 00:00

  • EE534 Economic Burden of Waldenström Macroglobulinemia, Marginal Zone Lymphoma and Chronic Lymphoid Leukemia

    Dec 1, 2023, 00:00

  • PCR111 Which Body Functions and Activities Matter for Stroke Patients? Study Protocol for Best–Worst Scalings to Value Core Elements of the ICF

    Dec 1, 2023, 00:00

  • EE576 Costs Saving Generated by Anti-TNF Biosimilars Market Penetration in Fran An Analysis Based on French Health Insurance Open Data

    Dec 1, 2023, 00:00

  • HTA57 Costing for Health Economics Evaluation: The Case of the Brazilian Universal Health System

    Dec 1, 2023, 00:00

  • EE461 An Italian Real-World Analysis of Economic Impact in Patients with Hypercholesterolemia Treated with Rosuvastatin/Ezetimibe as Free Vs Single-Pill Combination

    Dec 1, 2023, 00:00

  • CO56 Radiographic Progression Free Survival as a Surrogate Endpoint for Overall Survival Among Men With Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2023, 00:00

  • HPR84 Impact of AIFA Monitoring Registries Closure on Drugs’ Turnover Trends in Italy

    Dec 1, 2023, 00:00

  • EE287 Epidemiologic and Economic Impact of COVID-19 Vaccination Among at-Risk Individuals and Individuals Aged ≥60 Years in Germany

    Dec 1, 2023, 00:00

  • EE479 The Cost of Treating Gastroesophageal Reflux Disease: A Systematic Review

    Dec 1, 2023, 00:00

  • HTA205 EU Joint Clinical Assessments on Health Technologies Is Approaching—Are We Prepared?

    Dec 1, 2023, 00:00

  • MT57 Optimization of Patient Scheduling Based on AI Algorithm of the Radiotherapy Department of Liège University Hospital: Presentation of Selected Key Performance Indicators (KPIs) (HosmartAI - Horizon 2020 Funded)

    Dec 1, 2023, 00:00

  • PCR45 Vascular Access Devices: A Comparative Analysis of Complications and Their Cost Implications

    Dec 1, 2023, 00:00

  • OP6 Overcrowding and Boarding Time: Emergency Department Performance and Impacting Factors

    Dec 1, 2023, 00:00

  • EE443 Burden of Hospitalization Related to Adult Herpes Zoster Infection in Portugal

    Dec 1, 2023, 00:00

  • EE539 The Economic Burden of Systemic Drug Therapy Administration Route in Treating HER2-Positive Breast Cancer for Patients, Healthcare Professionals, and Healthcare System: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • HSD85 Patterns and Correlates of Physical Activity Among Nigerian Community-Dwelling Older Adults

    Dec 1, 2023, 00:00

  • Disclaimer

    Dec 1, 2023, 00:00

  • EE700 Are Acute Therapies and Curative Drugs More Affordable Than Chronic Treatments in Rare Diseases? An Analysis of the Top 10 Most Expensive Drugs in the US Compared with Germany

    Dec 1, 2023, 00:00

  • Impact of Regulatory Affairs on Access

    Dec 1, 2023, 00:00

  • EPH121 Contraindicated Remdesivir Use Among Individuals Hospitalized Due to COVID-19: According to the Danish Treatment Guidelines

    Dec 1, 2023, 00:00

  • P28 Medication Non-Adherence in Patients with Varying Levels of Depression Symptoms Measured Using the Medication Adherence Reasons Scale

    Dec 1, 2023, 00:00

  • MSR119 Statistical Methods to Examine Racial and Ethnic Disparities in the Surgical Literature: A Review and Recommendations for Improvement

    Dec 1, 2023, 00:00

  • MSR160 Screening Tools for Streamlining Systematic Literature Review Process: Reviewers' Perspective

    Dec 1, 2023, 00:00

  • PCR49 A Preliminary Comparison between Analytical Hierarchy Process and Discrete Choice Experiment in Health State Preferences in Hong Kong SAR, China

    Dec 1, 2023, 00:00

  • EE550 Lifetime Cost of Orphan Therapies in Paediatric Indications in Europe

    Dec 1, 2023, 00:00

  • MT41 Single-Use Vs Reusable Endoscope Reprocessing: A Staff Survey on Safety and Effectiveness

    Dec 1, 2023, 00:00

  • EE129 Health-Economic Analysis of Digestive Stents in France Based on the French Social Insurance Healthcare Database

    Dec 1, 2023, 00:00

  • PCR87 Collecting Exploratory Patient Preference Data Using an Efficient Approach: An Example in Rare Diseases

    Dec 1, 2023, 00:00

  • HTA129 Learnings from TC Opinions of Drugs Evaluated for EAP Under New Process

    Dec 1, 2023, 00:00

  • HTA44 Broadening the HTA of Medical AI: A Review of Policy Reports to Inform Decision Makers

    Dec 1, 2023, 00:00

  • EE195 Quantifying the Avoided Costs of a Switch to Ofatumumab From Low/Moderate Efficacy Disease Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis in Colombia

    Dec 1, 2023, 00:00

  • EE519 Do We Need Three-State Decision Analytic Models in Metastatic Oncology? An Alternative Approach to Estimate Quality Adjusted Life Years (QALY)

    Dec 1, 2023, 00:00

  • EE153 Using a Cumulative Low-Density Lipoprotein Cholesterol Modelling Approach to Estimate the Reduction of Risk of Atherosclerotic Cardiovascular Events from a Primary Prevention Program

    Dec 1, 2023, 00:00

  • CO141 Assessing the Impact of Additional Follow-up Data on Disease-Free Survival (DFS) Projections of Nivolumab and Surveillance in High-Risk, Muscle-Invasive Urothelial Carcinoma (MIUC) Patients Within the CheckMate-274 Trial

    Dec 1, 2023, 00:00

  • MT34 Adaptation and Cost-Effectiveness Analysis of the "My Health Everyday” Medication Adherence Coaching Application for Hypertension Management in Hungary

    Dec 1, 2023, 00:00

  • EE714 A De Novo Cost-Effectiveness Model to Evaluate the Real-World Value of Pegcetacoplan in the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration in the United States

    Dec 1, 2023, 00:00

  • SA62 A Methodological Approach for the Design of a Unique Post Market Clinical Follow-up Study for Standard and Custom-Made Devices According to EU Medical Device Regulation 2017/745

    Dec 1, 2023, 00:00

  • PT38 Budget Impact Analysis of rFVIII Glycopegylated-Exei for the Treatment of Haemophilia A in Colombia

    Dec 1, 2023, 00:00

  • MSR31 A Simulation Study to Examine the Influence of Varied Standard Deviation of Covariates across Trials on Population Adjusted Indirect Treatment Comparisons

    Dec 1, 2023, 00:00

  • MT36 Roadmap for Evidence Generation on Remote Monitoring Devices for Parkinson’s Disease

    Dec 1, 2023, 00:00

  • EPH183 The Effects of COVID-19 on Mental Health

    Dec 1, 2023, 00:00

  • HPR40 DiGA in Germany: Achievable Prices After Price Negotiation or a Decision of the Arbitration Board

    Dec 1, 2023, 00:00

  • HTA72 How Is Real-World Evidence (RWE) Being Used in Health Technology Assessment (HTA) Decisions? Qualitative Insights from Comparisons of Three RWE Study Types Across Multiple Jurisdictions

    Dec 1, 2023, 00:00

  • SA4 Characterization of Demography and Comorbidity in Newly Diagnosed Multiple Myeloma Patients in the UK

    Dec 1, 2023, 00:00

  • HPR181 Comprehensive and Standardized Value Assessment of Innovative Cancer Treatments: A Multi-Criteria Decision Analysis (MCDA) Tool for Switzerland

    Dec 1, 2023, 00:00

  • EPH84 Burden of Respiratory Syncytial Virus in Children ≤ 2 Years of Age in Germany: Retrospective Analysis of Health Claims Data from 2014-2019

    Dec 1, 2023, 00:00

  • HTA175 The Impact of Accelerated Regulatory Approval on Health Technology Assessment: An Evaluation of Orphan Drugs in Four Markets

    Dec 1, 2023, 00:00

  • HTA102 Exploring Potential Inequity in Access to Medicines for Ultra-Rare Disease in England and Scotland: SMC Ultra-Orphan Pathway Versus NICE HST

    Dec 1, 2023, 00:00

  • CO194 Integration of Clinical Outcome Assessments (COA) in Drug Approval Process to Foster Patient-Centric Clinical Trials: A Review of 3 Regulatory Guidelines for Drug Development in the APAC

    Dec 1, 2023, 00:00

  • P30 Do Novel Oncology Combination Therapies Have a Place Within the EU Legislative Framework? The Impact of Challenges for Novel Combination Therapies on Equality of Access Between European Patients

    Dec 1, 2023, 00:00

  • EE695 Cost-Effectiveness of a New Multi-Lumen Infusion Device to Reduce Central Venous Line-Related Infections in a Neonatal Intensive Care Unit

    Dec 1, 2023, 00:00

  • EE406 Budget Impact Analysis of Dupilumab 200 Mg for Treatment of Adolescent and Adult With Severe Asthma in Algerian Setting

    Dec 1, 2023, 00:00

  • EE312 Multi-Comparator ICERS in Cost-Effectiveness Analysis to Account for Changes in Clinical Practice after the Introduction of a New Technology

    Dec 1, 2023, 00:00

  • MT32 Predictive Factors of Communicating Health-Related Information through the Internet Among Adults in South Korea: A Cross-Sectional Study

    Dec 1, 2023, 00:00

  • HTA32 When Should the Conduct of RWE Studies Be Prioritized for Reimbursement: Insights from Canadian and Global Stakeholders

    Dec 1, 2023, 00:00

  • HTA330 EU HTA: How Will Joint Clinical Assessment (JCA) Address the Specifics of Gene Therapies?

    Dec 1, 2023, 00:00

  • EE215 Estimation of 10-Year Healthcare Costs of Patients Diagnosed With Myeloproliferative Neoplasms in Denmark

    Dec 1, 2023, 00:00

  • HPR67 Utilisation of Intermittent and Real-Time Continuous Blood Glucose Monitoring in the Irish Healthcare System

    Dec 1, 2023, 00:00

  • EE333 Cost-Effectiveness of Once-Weekly Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in the UK

    Dec 1, 2023, 00:00

  • EE172 An Early Economic Analysis of the Costs and Benefits of Medical Alert Assistance Dogs (MAADS) in the Management of Emergency Episodes for People with Postural Tachycardia Syndrome (POTS) Using Real-World Evidence (RWE)

    Dec 1, 2023, 00:00

  • HTA48 Bridging the Gap: How to Align HTA and Health Care Decision Making in Switzerland

    Dec 1, 2023, 00:00

  • PCR15 Impact of Amyotrophic Lateral Sclerosis on Work and Daily Living: Results from a Real-World Survey

    Dec 1, 2023, 00:00

  • EE430 Use of Single-Arm Trials in Health Technology Assessment Reviews of Axicabtagene Ciloleucel

    Dec 1, 2023, 00:00

  • P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States

    Dec 1, 2023, 00:00

  • MSR158 Successful Use of Propensity Score Methods for HTA in Germany: A Near-Impossible Task?

    Dec 1, 2023, 00:00

  • EPH247 Survival and Risk of Death Analysis of Patients with Myelofibrosis Treated with Ruxolitinib

    Dec 1, 2023, 00:00

  • HTA277 Requirements for Clinical Evidence for Health Technology Assessment Submissions Across Different Countries

    Dec 1, 2023, 00:00

  • SA16 Assessing the Validity of Observational Filters for Systematic and Rapid Literature Reviews

    Dec 1, 2023, 00:00

  • EE316 The Cost-Saving of the Introduction of Dapagliflozin in Algeria After Primary Failure of Oral Anti-Diabetics in Patients With Types 2 Diabetes (T2DM)

    Dec 1, 2023, 00:00

  • HSD103 Lifestyle Modifications and Medicines as the Foundation of Clinical Practice Guidelines

    Dec 1, 2023, 00:00

  • EE65 Evaluating the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Strategy in Oncology and Implications for Policy: A Literature Review

    Dec 1, 2023, 00:00

  • EPH204 Epidemiology and Patient Characteristics of Pemphigus Vulgaris in UK: A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

    Dec 1, 2023, 00:00

  • EE600 Prediction of Price Dynamics of Medicine in the Netherlands

    Dec 1, 2023, 00:00

  • RWD175 A Data Quality Framework to Assess Healthcare Data in Saudi Arabia: An Automated Approach

    Dec 1, 2023, 00:00

  • Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations [Editor's Choice]

    Nov 1, 2023, 00:00

  • Table of Contents

    Nov 1, 2023, 00:00

  • On the (Near) Equivalence of Welfarist and Extra-Welfarist Methods to Value Healthcare With Implications for Assessing Equity [Editor's Choice]

    Nov 1, 2023, 00:00

  • The Feasibility and Validity of Preference-Based Quality of Life Measures With Informal Carers: A Think-Aloud Study

    Nov 1, 2023, 00:00

  • Influence of Self-Reported Health Impairments on German EQ-5D-5L Values

    Nov 1, 2023, 00:00

  • A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons

    Nov 1, 2023, 00:00

  • Copyright/Subscription

    Nov 1, 2023, 00:00

  • Cancer Drug Prices in the United States: Efficacy, Innovation, Clinical Trial Evidence, and Epidemiology [Editor's Choice]

    Nov 1, 2023, 00:00

  • Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review: An ISPOR Special Interest Group Report

    Nov 1, 2023, 00:00

  • Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions [Editor's Choice]

    Nov 1, 2023, 00:00

  • Can Independently Elicited Adult- and Child-Perspective Health-State Utilities Explain Priority Setting?

    Nov 1, 2023, 00:00

  • UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol

    Nov 1, 2023, 00:00

  • Editorial Board

    Oct 30, 2023, 08:36

  • The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual [Editor's Choice]

    Oct 1, 2023, 00:00

  • Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice

    Oct 1, 2023, 00:00

  • Copyright/Subscription

    Oct 1, 2023, 00:00

  • A Qualitative Investigation to Develop an Adapted Version of the EQ-5D-Y-3L for Use in Children Aged 2-4 Years

    Oct 1, 2023, 00:00

  • A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE’s Size of Benefit Multiplier

    Oct 1, 2023, 00:00

  • Recognizing the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability, or Willingness?

    Oct 1, 2023, 00:00

  • Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis [Editor's Choice]

    Oct 1, 2023, 00:00

  • Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials

    Oct 1, 2023, 00:00

  • A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach [Editor's Choice]

    Oct 1, 2023, 00:00

  • Adaptive Health Technology Assessment: A Scoping Review of Methods [Editor's Choice]

    Oct 1, 2023, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration [Editor's Choice]

    Oct 1, 2023, 00:00

  • Table of Contents

    Oct 1, 2023, 00:00

  • Reporting Answer Categorization and Scoring Methods in the Criteria for Health Economic Quality Evaluation (CHEQUE) Tool

    Oct 1, 2023, 00:00

  • Author Reply

    Oct 1, 2023, 00:00

  • Extending Beyond Bagust and Beale: Fully Parametric Piecewise Exponential Models for Extrapolation of Survival Outcomes in Health Technology Assessment

    Oct 1, 2023, 00:00

  • Comparisons of Medical Cost Trajectories Between Non-Hispanic Black and Non-Hispanic White Patients With Newly Diagnosed Localized Prostate Cancer

    Oct 1, 2023, 00:00

  • Postacute Expenditures Among Patients Discharged Home After Stroke or Transient Ischemic Attack: The COMprehensive Post-Acute Stroke Services (COMPASS) Trial

    Oct 1, 2023, 00:00

  • Does Scoring Method Impact Estimation of Significant Individual Changes Assessed by Patient-Reported Outcome Measures? Comparing Classical Test Theory Versus Item Response Theory

    Oct 1, 2023, 00:00

  • The Integration of Value Assessment and Social Network Methods for Breast Health Navigation Among African Americans

    Oct 1, 2023, 00:00

  • Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure With Reduced Ejection Fraction: A Systematic Review

    Oct 1, 2023, 00:00

  • Editorial Board

    Sep 22, 2023, 12:54

  • Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation

    Sep 1, 2023, 00:00

  • A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness [Editor's Choice]

    Sep 1, 2023, 00:00

  • Impacts of Chronic Obstructive Pulmonary Disease Care Pathway on Healthcare Utilization and Costs: A Matched Multiple Control Cohort Study in Saskatchewan, Canada

    Sep 1, 2023, 00:00

  • Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior

    Sep 1, 2023, 00:00

  • Reimagining Patient Data Access for Researchers

    Sep 1, 2023, 00:00

  • A Rapid Review on the Value of Biobanks Containing Genetic Information

    Sep 1, 2023, 00:00

  • Streamlining Global and Local Data on HIV: Underscoring Role of Institutions and Ethics in Improving Quality of HIV Research

    Sep 1, 2023, 00:00

  • “What’s Sex and Gender Got to Do With It?” A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence

    Sep 1, 2023, 00:00

  • Does EQ-5D Tell the Whole Story? Statistical Methods for Comparing the Thematic Coverage of Clinical and Generic Outcome Measures, With Application to Breast Cancer [Editor's Choice]

    Sep 1, 2023, 00:00

  • Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs [Editor's Choice]

    Sep 1, 2023, 00:00

  • US Residents’ Preferences for Sharing of Electronic Health Record and Genetic Information: A Discrete Choice Experiment

    Sep 1, 2023, 00:00

  • Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments

    Sep 1, 2023, 00:00

  • A Model for Evaluating Total Costs of Care and Cost Savings of Specialty Condition-Based Care for Hip and Knee Osteoarthritis in an Integrated Practice Unit

    Sep 1, 2023, 00:00

  • Table of Contents

    Sep 1, 2023, 00:00

  • Use of Big Data and Ethical Issues for Populations With Substance Use Disorder

    Sep 1, 2023, 00:00

  • Data Privacy and Health: How Do We Achieve the Right Balance? [Editor's Choice]

    Sep 1, 2023, 00:00

  • Personal Location as Health-Related Data: Public Knowledge, Public Concern, and Personal Action

    Sep 1, 2023, 00:00

  • Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges [Editor's Choice]

    Sep 1, 2023, 00:00

  • The Societal Impact of Inclisiran in England: Evidence From a Population Health Approach

    Sep 1, 2023, 00:00

  • Mothers’ Views on the Storage and Usage of Their Children’s Biological Material Under the Danish Biobanking Model: A Narrative Approach Using Epistemic Injustice

    Sep 1, 2023, 00:00

  • Editorial Board

    Sep 1, 2023, 00:00

  • Balancing Data Privacy With Access to Health Services and Research: Facilitating Confidential Information Sharing in US Multisystem Collaborations

    Sep 1, 2023, 00:00

  • Copyright/Subscription

    Sep 1, 2023, 00:00

  • Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency Surgery

    Aug 1, 2023, 00:00

  • Patients’ and Healthcare Professionals’ Perspectives on Better Use of Patient-Reported Outcome Measures in Head and Neck Cancer

    Aug 1, 2023, 00:00

  • Dynamic Mortality Modeling: Incorporating Predictions of Future General Population Mortality Into Cost-Effectiveness Analysis

    Aug 1, 2023, 00:00

  • A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report [Editor's Choice]

    Aug 1, 2023, 00:00

  • The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases [Editor's Choice]

    Aug 1, 2023, 00:00

  • Inclusion of Environmental Spillovers in Applied Economic Evaluations of Healthcare Products

    Aug 1, 2023, 00:00

  • Copyright/Subscription

    Aug 1, 2023, 00:00

  • The Healthcare Cost Burden of Asthma in Children: A Longitudinal Population-Based Study

    Aug 1, 2023, 00:00

  • Frameworks for Health Technology Assessment at an Early Stage of Product Development: A Review and Roadmap to Guide Applications

    Aug 1, 2023, 00:00

  • Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma

    Aug 1, 2023, 00:00

  • Comparing Patient-Reported Outcomes Measurement Information System Computer Adaptive Testing With Existing Measures After Operative Interventions for Extremity Fractures

    Aug 1, 2023, 00:00

  • Instructions for Authors

    Aug 1, 2023, 00:00

  • Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines

    Aug 1, 2023, 00:00

  • Table of Contents

    Aug 1, 2023, 00:00

  • Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring ME T Exon 14 Skipping

    Aug 1, 2023, 00:00

  • How Uncertainty Matters Under Risk Neutrality

    Aug 1, 2023, 00:00

  • Developing Criteria for Health Economic Quality Evaluation Tool [Editor's Choice]

    Aug 1, 2023, 00:00

  • The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non–Small Cell Lung Cancer

    Aug 1, 2023, 00:00

  • Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development [Editor's Choice]

    Aug 1, 2023, 00:00

  • Cost-Effectiveness and Long-Term Savings of the Bright Bodies Intervention for Childhood Obesity

    Aug 1, 2023, 00:00

  • Editorial Board

    Jul 28, 2023, 10:22

  • Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey

    Jul 1, 2023, 00:00

  • The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies

    Jul 1, 2023, 00:00

  • Health Technology Assessment–Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England [Editor's Choice]

    Jul 1, 2023, 00:00

  • Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force

    Jul 1, 2023, 00:00

  • Methods to Adjust Willingness-to-Pay Measures for Severity of Illness [Editor's Choice]

    Jul 1, 2023, 00:00

  • Public Preferences for Policies to Promote COVID-19 Vaccination Uptake

    Jul 1, 2023, 00:00

  • Deriving Meaningful Aspects of Health Related to Physical Activity in Chronic Disease: Concept Elicitation Using Machine Learning–Assisted Coding of Online Patient Conversations

    Jul 1, 2023, 00:00

  • Valuing the EQ Health and Wellbeing Short Using Time Trade-Off and a Discrete Choice Experiment: A Feasibility Study

    Jul 1, 2023, 00:00

  • Developing, Selecting, and Modifying Performance Outcome Assessments

    Jul 1, 2023, 00:00

  • Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario? [Editor's Choice]

    Jul 1, 2023, 00:00

  • Using Time Trade-Off Values to Estimate EQ-5D-Y Value Sets: An Exploratory Study

    Jul 1, 2023, 00:00

  • Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting

    Jul 1, 2023, 00:00

  • Quality-Adjusted Life Expectancy Norms for Italy

    Jul 1, 2023, 00:00

  • The Value of Vaccines in Maintaining Health System Capacity in England

    Jul 1, 2023, 00:00

  • Value of an Integrated Home Dialysis Model in the United Kingdom: A Cost-Effectiveness Analysis

    Jul 1, 2023, 00:00

  • Table of Contents

    Jul 1, 2023, 00:00

  • Intention to Treat or per Protocol? Overly Optimistic Findings Regarding the Cost-Effectiveness of 99DOTS, a Tuberculosis Digital Adherence Technology

    Jul 1, 2023, 00:00

  • Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions

    Jul 1, 2023, 00:00

  • A Direct Comparison of the Measurement Properties of EQ-5D-5L, PROMIS-29+2 PROMIS Global Health Instruments and EQ-5D-5L and PROPr Utilities in a General Population Sample [Editor's Choice]

    Jul 1, 2023, 00:00

  • Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes Medications [Editor's Choice]

    Jul 1, 2023, 00:00

  • Revising the Suspected-Cancer Guidelines: Impacts on Patients’ Primary Care Contacts and Costs

    Jul 1, 2023, 00:00

  • Copyright/Subscription

    Jul 1, 2023, 00:00

  • The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39

    Jul 1, 2023, 00:00

  • Use of Utility and Disability Weights in Economic Evaluation of Pediatric Vaccines

    Jul 1, 2023, 00:00

  • Editorial Board

    Jun 28, 2023, 09:01

  • Editorial Board

    Jun 1, 2023, 08:52

  • Medical Technologies

    Jun 1, 2023, 00:00

  • MT38 Novel Data Capture Method for the Identification of Potential Flare Events in Chronic Diseases Via Patient Self-Tracking: Insights from Use Case in Sickle Cell Disease (SCD)

    Jun 1, 2023, 00:00

  • CO174 Prescription Patterns of Antidiabetic Agent and Renal Effectiveness Among Patients with Diabetic Kidney Disease

    Jun 1, 2023, 00:00

  • RWD50 Characteristics of Health Insurance Coverage in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States

    Jun 1, 2023, 00:00

  • EE562 Cost-Effectiveness of the Dengue Vaccine TAK-003 in Thailand

    Jun 1, 2023, 00:00

  • PCR70 Patient and Physician Concordance in Treatment Satisfaction and Symptom Severity Among Male and Female Myasthenia Gravis Patients in the United States and Five European Countries

    Jun 1, 2023, 00:00

  • EE45 Cost-Effectiveness of Venetoclax in Combination with Rituximab in Relapsed/Refractory Chroniclymphocytic Leukemia in Four Gulf Countries

    Jun 1, 2023, 00:00

  • Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma

    Jun 1, 2023, 00:00

  • CO124 Real-World Reduction of Oral Corticosteroid Use in Patients Treated with Dupilumab and with Moderate-to-Severe Asthma

    Jun 1, 2023, 00:00

  • HPR146 Specialty Pharmacy Use and Adherence to Oral Anticancer Medications for Breast Cancer and Prostate Cancer: Implications for Medicare Part D Policy

    Jun 1, 2023, 00:00

  • EE248 Patient-Informed Value Elements for Economic Evaluation of Treatment for Major Depressive Disorder: A Systematic Review and Synthesis

    Jun 1, 2023, 00:00

  • CO163 Associations between Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIS) and Venous Thromboembolism Among Older Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2023, 00:00

  • EE258 National Trends in Costs and Site of Service of Infused Disease Modifying Therapies for Multiple Sclerosis

    Jun 1, 2023, 00:00

  • SA33 Healthcare Utilization Among Veterans with Alzheimer's Disease Identified from Clinical Notes

    Jun 1, 2023, 00:00

  • EE76 Budget Impact of Faricimab in Patients with Diabetic Macular Edema and Neovascular Age Related Degeneration in Canada

    Jun 1, 2023, 00:00

  • CO43 Burden of Surgery in Desmoid Tumors

    Jun 1, 2023, 00:00

  • EE495 Cost-Effectiveness of Pembrolizumab + Axitinib Versus Nivolumab + Ipilimumab As First-Line Treatment of Advanced Renal Cell Carcinoma in the Private Healthcare System in Brazil

    Jun 1, 2023, 00:00

  • CO36 Keratometry, Intraocular Pressure, and Visual Acuity at the Onset of Ophthalmic Conditions in the Real-World Setting

    Jun 1, 2023, 00:00

  • MSR107 Assessment of the Power of ITCs to Detect Minimally Important Treatment Effects in Subsequent Head-to-Head Trials

    Jun 1, 2023, 00:00

  • EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture

    Jun 1, 2023, 00:00

  • EPH97 Application of Self-Protective Behaviors in Balancing Objective and Subjective COVID-19 Risk Assessments Among Residents in an Urban Setting

    Jun 1, 2023, 00:00

  • EPH26 Barriers to in-Person Focus Group Participation during the Third-Year of COVID-19 Pandemic: A Case Study of Colorectal Cancer (CRC) Screening in Underrepresented Groups

    Jun 1, 2023, 00:00

  • SA25 A Novel Patient-Reported Outcome Instrument for Meibomian Gland Dysfunction Disease Impact

    Jun 1, 2023, 00:00

  • CO180 Persistent Opioid Use after Hospital Admissions for Surgery in New Zealand

    Jun 1, 2023, 00:00

  • RWD68 Early Optimal Recovery As a Composite Outcome to Measure Value of Care in Patients Undergoing Primary Total Knee Arthroplasty with a New Implant Design

    Jun 1, 2023, 00:00

  • PCR37 Translation and Cultural Adaptation of the Glaucoma Quality of Life-15 Questionnaire to the Romanian Population

    Jun 1, 2023, 00:00

  • PCR12 Delayed Care Among Low-Income Adults during the COVID-19 Pandemic: A US Population-Based Study

    Jun 1, 2023, 00:00

  • PCR131 Expanded Diagnoses Outside of Specialized Amyloidosis Centers: Results from the Amyloidosis Research Consortium's 2022 Community Survey

    Jun 1, 2023, 00:00

  • RWD71 Managing Uncertainty in US and Spain: How Can Outcomes-Based Agreements Provide Solutions to This?

    Jun 1, 2023, 00:00

  • CO179 Potential Health and Economic Outcomes of a Blood-Based Genomic Test As a Prescreen for Lung Cancer in the US Medicare Population

    Jun 1, 2023, 00:00

  • P43 Critical Appraisal of Drug Pricing for Advanced Breast Cancer Medications Approvals in Brazil (2007 - 2022) and Comparison with Major National Economic Indicators

    Jun 1, 2023, 00:00

  • MSR14 Association of Social Determinants of Health and HIV Pre-Exposure Prophylaxis (PREP) to Need Ratio on the County Level in the United States

    Jun 1, 2023, 00:00

  • HSD70 Strategies Used and Degree of Implementation of Clinical Practice Guidelines during the Year 2022 in Colombia: Descriptive Observational Study

    Jun 1, 2023, 00:00

  • EE296 The Total Cost of Preeclampsia in the Ecuadorian Health System

    Jun 1, 2023, 00:00

  • MSR29 Application of Bayesian Multi-Parameter Evidence Synthesis to Achieve Clinical Plausibility of Lifetime Survival Extrapolations in First-Line Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Jun 1, 2023, 00:00

  • MSR94 Unraveling the Threads of Overlapping Coverage Among the Three Most Commonly Explored Biomedical Databases

    Jun 1, 2023, 00:00

  • HPR12 Patient Reported Outcomes in Psoriasis Over Time: Differences By Sex from Three Cross-Sectional, Real World Studies in the United States

    Jun 1, 2023, 00:00

  • PCR57 The Role of Patient Activation and Social Support in Health Management Among US Adults with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • EPH86 Associations between Depression and HIV Testing / Risk Behaviors in the United States

    Jun 1, 2023, 00:00

  • RWD97 Implementing a Quality Assurance Program for Technology-Enabled Curation of Oncology Real-World Data

    Jun 1, 2023, 00:00

  • MSR17 Imputation of Line-Level Medical Costs Using a Gradient Descent Boosting Regressor Model

    Jun 1, 2023, 00:00

  • EE457 Major Ischemic or Hemorrhagic Events and Associated Costs Among Anticoagulated Patients with Non-Valvular Atrial Fibrillation in US Health Plans

    Jun 1, 2023, 00:00

  • EPH62 Annual Burden of Non-COVID-19 Respiratory Tract Infections in the Pre- to Post- Pandemic Eras: Analysis from the Anlitiks’ All Payor Claims Database

    Jun 1, 2023, 00:00

  • MT42 HTA Landscape of Medical Devices in Canada

    Jun 1, 2023, 00:00

  • EE188 Budget Impact Analysis of Faricimab for Treating Patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Panama

    Jun 1, 2023, 00:00

  • HTA67 Evidence Gaps in Evaluating Comparative Effectiveness, Safety, and Cost-Effectiveness of Biologics in Health Technology Assessment (HTA) Submissions for the Treatment of Severe Asthma

    Jun 1, 2023, 00:00

  • CO217 Treatment Options for Management of Facial Angiofibroma Associated with Tuberous Sclerosis Complex: A Systematic Review of Evidence of Clinical Effectiveness and Cost-Effectiveness

    Jun 1, 2023, 00:00

  • EE44 Estimating a Cost-Effectiveness Threshold for Health Care Decision-Making in China: Oncology Prevention Versus Treatment

    Jun 1, 2023, 00:00

  • PCR160 Suitability of Patient-Reported Outcomes Measure Information System (PROMIS) Parent Proxy (PP) Mobility Questionnaire in Typically Developing Children Aged 3-4 Years

    Jun 1, 2023, 00:00

  • EE424 Economic Burden of Chronic Kidney Disease in India: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • RWD124 Understanding the Value of Chart Abstraction for Assessing Oral Treatment History in the Oncology Outpatient Setting

    Jun 1, 2023, 00:00

  • MSR58 Relating Heterotopic Ossification Volume to Joint Function And Quality of Life: A Simulation Study in Fibrodysplasia Ossificans Progressiva (FOP)

    Jun 1, 2023, 00:00

  • HTA49 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in El Salvador

    Jun 1, 2023, 00:00

  • EE568 Challenges to Hepatitis C Treatment Access in Vietnam: A Micro-Costing Study

    Jun 1, 2023, 00:00

  • EE37 Economic Burden Associated with Immune-Related Adverse Events Induced By Immune Checkpoint Inhibitors Among Older Adults with Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • CO117 Real-World Treatment Patterns and Outcomes in Unresectable Advanced and Metastatic Biliary Tract Cancers (BTC): A Literature Review

    Jun 1, 2023, 00:00

  • CO176 Spinal Muscular Atrophy (SMA) Disease-Related Complications Decreased Over Time after Start of Nusinersen Treatment

    Jun 1, 2023, 00:00

  • EPH10 Carbapenem-Resistant Gram-Negative Pathogens in Brazil: Analysis from Patients in a Laboratory Network

    Jun 1, 2023, 00:00

  • HSD68 Improving Care Via Timely Health Information Exchange: A Blue Cross and Blue Shield of Louisiana ADT System Referral Program Evaluation

    Jun 1, 2023, 00:00

  • EPH2 Using Drug Package Insert Data to Identify Statin-Related Prescribing Cascades - an Evaluation of Findings from Side Effect Resource (SIDER) and Commercial Claims Data

    Jun 1, 2023, 00:00

  • HSD77 Use and Prescribing Patterns of Disease Modifying Agents in Patients with Multiple Sclerosis Based on Payer Type and Prescribers’ Specialty

    Jun 1, 2023, 00:00

  • CO80 Improvements in Activity and Work Productivity in Patients Treated with Mepolizumab across Eosinophilic Diseases

    Jun 1, 2023, 00:00

  • HPR31 Value-Based Purchasing Arrangements in Medicaid Programs: Targeted Review

    Jun 1, 2023, 00:00

  • CO189 Metabolic and Bariatric Surgery Utilization Trends in the United States: Evidence from 2012–2021 National Electronic Medical Records Data

    Jun 1, 2023, 00:00

  • EE23 Economic Impact of Discontinuation and Relapse Rates Among Patients with Schizophrenia Newly Initiated on Lybalvi Versus Olanzapine during First Year Use

    Jun 1, 2023, 00:00

  • EE449 Use of Novel and Social Elements of Value in Cost-Effectiveness Analyses

    Jun 1, 2023, 00:00

  • PCR147 Investigating the Patterns of Health-Related Quality of Life and Factors Associated with It Using Latent Class Analysis Among West Virginians

    Jun 1, 2023, 00:00

  • HSD110 Trends in the Therapeutic Management of Localized Scleroderma in the Real-World Setting

    Jun 1, 2023, 00:00

  • HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?

    Jun 1, 2023, 00:00

  • HPR145 Authorizations of Therapeutic Biologics in Saudi Arabia and the US (1982-2021)

    Jun 1, 2023, 00:00

  • HSD5 Patient and Caregiver Spinal Muscular Atrophy (SMA) Treatment Attribute Preferences in Latin America

    Jun 1, 2023, 00:00

  • PCR110 Characteristics and Comorbid Conditions Associated with Treatment Discontinuation Among Patients Being Treated for Obesity

    Jun 1, 2023, 00:00

  • PCR217 Healthcare Resource Utilization Among Hormone Receptor-Positive and Negative Breast Cancer Patients in the Real-World Setting

    Jun 1, 2023, 00:00

  • EE301 Patient Characteristics, Healthcare Resource Utilization, and Costs for Persistent Chronic Cough Vs. Chronic Cough without Persistent Cough in the United States

    Jun 1, 2023, 00:00

  • CO227 An Updated Umbrella Review Comparing the Safety and Effectiveness of Femtosecond Laser-Assisted Cataract Surgery with Manual Cataract Surgery

    Jun 1, 2023, 00:00

  • EPH134 Accurately Counting Cancer Patients: An Epidemiologic Model to Estimate the Prevalence of Epithelial Ovarian Cancer (EOC) While Accounting for Cure

    Jun 1, 2023, 00:00

  • RWD105 To What Extent Is Allocation of Higher KDPI Score Kidney Transplantation Occurring in the US?

    Jun 1, 2023, 00:00

  • RWD157 Healthcare Resource Utilization and Cost of Care in Patients with BRAF-Mutated Unresectable/Metastatic Melanoma in the US

    Jun 1, 2023, 00:00

  • EE430 Cost-Effectiveness of Tremelimumab or Tremelimumab in Combination with Durvalumab Vs Durvalumab As Treatment of Advanced Hepatocellular Carcinoma

    Jun 1, 2023, 00:00

  • EE285 Evaluating the Face Validity of Health State Utility Values (HSUVS) for Metachromatic Leukodystrophy (MLD)

    Jun 1, 2023, 00:00

  • Study Approaches

    Jun 1, 2023, 00:00

  • EE360 Measuring Catastrophic Costs Due to Tuberculosis in Colombia, 2021

    Jun 1, 2023, 00:00

  • EPH76 Association of Lynch Syndrome with Breast Cancer: An Exploratory Analysis Using Claims Data

    Jun 1, 2023, 00:00

  • EE243 Cost-Effectiveness of Velpatasvir/Sofosbuvir for the Treatment of Hepatitis C in Colombia

    Jun 1, 2023, 00:00

  • CO197 Burden of Disease Associated with Bictegravir/Tenofovir Alafenamide/Emtricitabine in Adults Infected with Human Immunodeficiency Virus Type 1: A Rapid Systematic Review

    Jun 1, 2023, 00:00

  • RWD7 Reproduction of the Control Group in REMDACTA Trial Using the Millennial Medical Record, an Electric Health Record Database, in Japan

    Jun 1, 2023, 00:00

  • EE29 Cost-Effectiveness Analysis and Budgetary Impact of Telescopic Rods for Treatment of Fractures and Correction of Bone Deformities in Children with Osteogenesis Imperfecta in the Brazilian Public Health System

    Jun 1, 2023, 00:00

  • PCR80 Analysis of the Use of Instruments for Collecting Patient-Reported Outcomes (PROS) in Pediatric Asthma Research

    Jun 1, 2023, 00:00

  • HSD13 Emergency Department Hyperkalemia Outcomes Are Improved with Newer Potassium Binders

    Jun 1, 2023, 00:00

  • CO27 Real-World Treatment Response and Persistence Among Black and Non-Black Patients with Metastatic Castration-Sensitive Prostate Cancer Treated with Apalutamide in a Urology Setting

    Jun 1, 2023, 00:00

  • EE227 The Impact of Treatment-Related Changes in Lipids on the Cost-Effectiveness of Resmetirom and Obeticholic Acid for Treatment of Nonalcoholic Steatohepatitis

    Jun 1, 2023, 00:00

  • CO157 Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

    Jun 1, 2023, 00:00

  • PCR245 Native Arabic Children Speakers' Inputs on the Arabic Translation of International Questionnaires Measuring Fatigue

    Jun 1, 2023, 00:00

  • EPH87 COPD Exacerbation Profile in Chile: Preliminary Results from Integramédica Cohort 2018–2020

    Jun 1, 2023, 00:00

  • SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • PCR77 “It Shocks Me That There Is Not Something like This Already in Place”: Patient Perspectives for Enhancing Pan-Canadian Data Sharing for Precision Oncology

    Jun 1, 2023, 00:00

  • RWD78 Characterization of Patients Treated with Semaglutide 2.4MG for Chronic Weight Management: A Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • MSR95 Impact of Adherence on Real-World Performance of Multi Cancer Early Detection (MCED) Tests: A Model-Based Analysis

    Jun 1, 2023, 00:00

  • EE36 Cost-Effectiveness Analysis of Taptest and Continuous Lumbar Drainage in Comparison to Standard Care in Suspected Idiopathic Normal Pressure Hydrocephalus from the Perspective of the Brazilian Unified Health System

    Jun 1, 2023, 00:00

  • CO142 Evaluating the Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Outcomes in the Stroke Belt

    Jun 1, 2023, 00:00

  • HTA68 How Do ICER’s Assessments of Comparative Effectiveness Compare to the German Federal Joint Committee’s Assessments of Added Benefit?

    Jun 1, 2023, 00:00

  • CO71 The Impact of Socioeconomic Status (SES), Insurance Type, and Treatment Facility on Survival in Metastatic Prostate Cancer (MPC): A Systematic Literature Review (SLR) of Social Determinants of Health (SDOH)

    Jun 1, 2023, 00:00

  • EE486 Osteoporosis Treatment Ranking in Postmenopausal Women at High Risk of Fracture in Brazil: MCDA Approach

    Jun 1, 2023, 00:00

  • SA27 Utility Maximization Vs Regret Minimization: Choice Behavior Under Uncertainty

    Jun 1, 2023, 00:00

  • CO53 Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study

    Jun 1, 2023, 00:00

  • RWD167 Clinical Characteristics, Patterns of Care and Healthcare Resource Utilization (HCRU) in US Patients with Claims for Uterine Fibroids (UF) and Heavy Menstrual Bleeding (HMB) Stratified By Race

    Jun 1, 2023, 00:00

  • HSD81 Trends in Systemic Therapy Utilization Among Older Patients with Advanced Cutaneous Melanoma: A Population-Based Study

    Jun 1, 2023, 00:00

  • HPR32 Tracking Progress Towards Equitable Maternal and Child Health in Yunnan: A Systematic Assessment for the Health Programme for Poverty Alleviation in China during 2015-2020

    Jun 1, 2023, 00:00

  • RWD18 Age Comparisons across Real-World Evidence Research, Randomized Clinical Trials, and Surveillance, Epidemiology, and End Results (SEER) in Advanced Cancer

    Jun 1, 2023, 00:00

  • PCR3 Pain-Free Injections for Growth Hormone Deficiency (GHD) Improve Quality of Life: A Time Trade-Off (TTO) Study in the UK and Canada

    Jun 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20 (current)
  • »